Transforming Treatment, End Notes
- S Nassir Ghaemi, “Symptomatic Versus Disease-modifying Effects of Psychiatric Drugs,” Acta Psychiatrica Scandinavica 146, no.3 (June 2, 2022): 251-57, https://doi.org/10.1111/acps.13459.
- Giorgio Samorini, “The Oldest Representations of Hallucinogenic Mushrooms in the world (Sahara Desert, 9000-7000 B.P.),” Integration Journal of Mind-moving Plants and Culture, no.2/3 (1992).
- Stephen Berlant, The entheomycological origin of Egyptian crowns and the esoteric underpinnings of Egyptian religion, image, Scientific Figure on ResearchGate, Accessed December 14, 2022, 2023.https://www.researchgate.net/figure/Left-Glyphs-of-mushroom-crowned-humanoids-on-cliffs-in-Chukchi-region-of-Russia_fig4_7566286.
- Mark J. Plotkin, “Richard Evans Schultes: Brief life of a pioneering ethnobotanist and conservationist: 1915-2001,” Harvard Magazine, Accessed 2023, https://www.harvardmagazine.com/profile/mark-j-plotkin.
- Gordon Wasson, “Seeking the Magic Mushrooms,” LIFE (May 13, 1957).
- “Psychedelic Research Timeline,” Beckley Foundation, Last modified 2016, https://www.beckleyfoundation.org/psychedelic-research-timeline-2/.
- “Timothy Leary,” Harvard University, Accessed April 11, 2023, https://psychology.fas.harvard.edu/people/timothy-leary.
- Controlled Substances Act, Public Law 91-513, October 27, 1970.
- Huberman, “How Psilocybin Can Rewire Our Brain, Its Therapeutic Benefits, & Its Risks, “ Podcast from Huberman Lab, May 2023.
- “Psychedelics Research and Psilocybin Therapy,” Johns Hopkins Medicine, visited April 12, 2023, https://www.hopkinsmedicine.org/psychiatry/research/psychedelics-research.html.
- Search of PubMed for all papers with “psilocybin” in the title or abstract.
- “COMP360 psilocybin therapy shows potential in exploratory open-label studies for anorexia nervosa and severe treatment resistant depression,” Compassion, Last modified May 3, 2022, https://www.globenewswire.com/news-release/2022/05/03/2434369/0/en/COMP360-psilocybin-therapy-shows-potential-in-exploratory-open-label-studies-for-anorexia-nervosa-and-severe-treatment-resistant-depression.html. “Evaluation of Psilocybin in Anorexia Nervosa: Safety and Efficacy,” Clinical Trials, July 25, 2022, https://clinicaltrials.gov/ct2/show/study/NCT04661514?term=psilocybin&recrs=ade&phase=012&draw=1&rank=28.
- Alan K Davis et al, “Effects of Psilocybin-Assisted Terapy on Major Depressive Disorder: A Randomized Clinical Trial, JAMA Psychiatry, vol. 5 (2021): 481-489, https://doi.org/10.1001/jamapsychiatry.2020.3285. Guy M. Goodwin et al, “Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression,” The New England Journal of Medicine, vol. 387, 18 (2022): 1637-1648, https://doi.org/10.1056/NEJMoa2206443.
- Michael P Bogenshutz et al, “Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder: A Randomized Clinical Trial,” Jama psychiatry, vol 79,10 (2022): 953-962, https://doi.org/10.1001/jamapsychiatry.2022.2096.
- Natalie Gukasyan, “Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up,” Journal of Psychopharmacology, vol 36, 2 (February 15, 2022): 151-158, https://doi.org/10.1177/02698811211073.
- Vanessa McMains, “Psychedelic Treatment with Psilocybin Shown to Relieve Major Depression,” Johns Hopkins University, Last modified Nov 11, 2020, https://hub.jhu.edu/2020/11/11/psilocybin-rapidly-treats-depression/#:~:text=The%20antidepressant%20effect%20of%20the,antidepressants%20currently%20on%20the%20market.
- David Nutt, Leslie King, Lawrence Phillips, “Drug harms in the UK: a multicriteria decision analysis,” Neuropsychopharmacology Unit, Imperial College, London, UK (November 12, 2010): https://DOI.org/10.1016/S0140- 6736(10)61462-6.
- Robert S. Gable, “Comparison of acute lethal toxicity of commonly abused psychoactive substances,” Addiction, vol. 99,6 (2004): 686-96, https://doi.org/10.1111/j.1360-0443.2004.00744.
- Erich Studerus, “Acute, subacute, and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of eight experimental studies,” Journal of Psychopharmacology, vol. 25,11 (2011): 1434-52, https://doi.org/10.1177/0269881110382466.
- “The Five Most Addictive Substances in the World,” County of Prince George Virginia, Last modified 2021, https://www.princegeorgecountyva.gov/news_detail_T6_R1533.php.
- 21 USC 811(c)
- Matthew W. Johnson, “The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act,” Neuropharmacology, vol. 142 (2018): 143-166, https://doi.org/10.1016/j.neuropharm.2018.05.012.
- “Change to classification of psilocybin and MDMA to enable prescribing by authorised psychiatrists,” Australian Government Department of Health and Aged Care, Last modified February 3, 2023, https://www.tga.gov.au/news/media-releases/change-classification-psilocybin-and-mdma-enable-prescribing-authorised-psychiatrists.
- “Oregon Psilocybin Services,” Oregon Health Authority, Accessed 2023, https://sharedsystems.dhsoha.state.or.us/DHSForms/Served/le4226.pdf.
- Natural Medicine Health Act of 2022, February 4, 2022, https://www.sos.state.co.us/pubs/elections/Initiatives/titleBoard/filings/2021-2022/58Final.pdf.
- Senate Bill 709, Maryland, Accessed 2023, https://mgaleg.maryland.gov/2022RS/bills/sb/sb0709t.pdf.
- Tom Angell, “Denver Voters Approve Measure to Decriminalize Psychedielic Mushrooms, Forbes, Last Modified May 8, 2019, https://www.forbes.com/sites/tomangell/2019/05/08/denver-voters-approve-measure-to-decriminalize-psychedelic-mushrooms/?sh=780bda9d3ddc.
- Merrit Kennedy, “Oakland City Council Effectively Decriminalizes Psychedelic Mushrooms,” NPR, Last modified June 5, 2019, https://www.npr.org/2019/06/05/730061916/oakland-city-council-effectively-decriminalizes-psychedelic-mushrooms. Harmeet Kaur, “Santa Cruz Decriminalizes Magic Mushrooms and Other Natural Psychedelics, Making it the Third US City to Take Such a Step,” Central News Network, accessed August 26, 2022, https://www.cnn.com/2020/01/30/us/santa-cruz-mushrooms-psychedelics-trnd/index.html; https://apnews.com/article/ann-arbor-plants-featured-ca-state-wire-mi-state-wire-b0ce69ca0961c150e0f900e8ea4cf432. Andrew Beaujon, “It Sure Looks Like DC Has Decriminalized Magic Mushrooms,” Washingtonian, Last modified November 4, 2020, https://www.washingtonian.com/2020/11/04/it-sure-looks-like-dc-has-decriminalized-magic-mushrooms/.
- Deborah Becker, “Cambridge Votes to Decriminalize Psychedelics and All Controlled Substances,” accessed August 26, 2022, https://www.wbur.org/news/2021/02/04/cambridge-votes-to-decriminalize-psychedelics-and-all-controlled-substances. “Office of the City Clerk,” Seattle.gov, Accessed 2023, https://seattle.legistar.com/LegislationDetail.aspx?ID=5154227&GUID=2EA44FD1-EDC3-42F2-9F03-291D714C7956&FullText=1https://www.pbs.org/newshour/politics/detroit-just-decriminalized-psychedelics-and-magic-mushrooms-heres-what-that-means. AJ Herrington, “Washington City Votes to Decriminalize Psychedelics,” Forbes, Accessed 2023, https://www.forbes.com/sites/ajherrington/2021/12/22/washington-city-votes-to-decriminalize-psychedelics/?sh=3b82afa61f42.
- “SB-58 Controlled substances: decriminalization of certain hallucinogenic substances,” California Legislative Information, Last modified September 11, 2023, https://leginfo.legislature.ca.gov/faces/billTextClient.xhtml?bill_id=202320240SB58.
- “Substitute for Raised H.B. No. 6734 Session Year 2023, Connecticut General Assembly, Last modified December 18, 2023, https://www.cga.ct.gov/asp/cgabillstatus/cgabillstatus.asp?selBillType=Bill&bill_num=HB06734&which_year=2023.
- “HB 549 (2021) – Use of Psilocybin for Mental Health Treatment,” Florida House of Representatives, Accessed 2023, https://www.myfloridahouse.gov/Sections/Bills/billsdetail.aspx?BillId=70865.
- “Bill Status of HB0001,” Illinois General Assembly, Accessed 2023, https://www.ilga.gov/legislation/BillStatus.asp?DocNum=1&GAID=17&DocTypeID=HB&SessionID=112&GA=103.
- “Legislation: Bill Information,” The Iowa Legislature, Accessed 2023, https://www.legis.iowa.gov/legislation/BillBook?ga=89&ba=HF459.
- “House Bill No. 2465,” Legislature of the State of Kansas, Accessed 2023, http://kslegislature.org/li_2022/b2021_22/measures/documents/hb2465_00_0000.pdf.
- “ME LD1582: An Act To Enact the Maine Psilocybin Services Act,” Bill Track 50, Accessed 2023, https://www.billtrack50.com/BillDetail/1367957.
- “Bill H.1754: An Act Relative to Plant Medicine,” The General Court of the Commonwealth of Massachusetts, Accessed 2023, https://malegislature.gov/Bills/193/HD1450.
- “Senate Bill 0631,” Michigan Legislature, Accessed 2023, https://www.legislature.mi.gov/(S(rshuwkbcyfwd3g5oiucjxxd2))/mileg.aspx?page=getObject&objectname=2021-SB-0631.
- “102nd General Assembly, 1st Regular Session, HB 1154,” Missouri House of Representatives, Accessed 2023, https://www.house.mo.gov/Bill.aspx?bill=HB1154&year=2023&code=R.
- “HB 955: Legalize psilocybin use for PTSD / mental illness treatment,” 2023 Capitol Tracker, Accessed 2023, https://apps.montanafreepress.org/capitol-tracker-2023/bills/hb-955/.
- “SB242,” Nevada Electronic Legislative Information System, Accessed 2023, https://www.leg.state.nv.us/App/NELIS/REL/82nd2023/Bill/10067/Overview.
- “New Hampshire House Bill 328,” Legiscan, Accessed 2023, https://legiscan.com/NH/text/HB328/2023.
- “Bill S2934 Session 2022-2023,” New Jersey Legislature, Accessed 2023, https://www.njleg.state.nj.us/bill-search/2022/S2934/bill-text?f=S3000&n=2934_I1.
- “Assembly Bill A8569A 2021-2022 Legislative Session,” The New York State Senate, Accessed 2023, https://www.nysenate.gov/legislation/bills/2021/A8569.
- Annie Szatkowski, “North Carolina bill drafted on psychedelic-assisted therapy research,” Fox 8, Last updated March 23, 2023, https://myfox8.com/news/north-carolina/north-carolina-bill-drafted-on-psychedelic-assisted-therapy-research/.
- “Bill Information for HB 2107,” Oklahoma State Legislature, Accessed 2023, http://www.oklegislature.gov/BillInfo.aspx?Bill=hb2107&Session=2300.
- “Rhode Island Senate Bill 806,” Legiscan, Accessed 2023, https://legiscan.com/RI/bill/S0806/2023#:~:text=Rhode%20Island%20Senate%20Bill%20806&text=Amends%20law%20on%20controlled%20substances,person%27s%20residence%20for%20personal%20use.
- “S.B. 200 Psilocybin Recommendation Pilot Program Amendments,” Utah State Legislature, Accessed 2023, https://le.utah.gov/~2023/bills/static/SB0200.html.
- “H.423 2023-2024,” Vermont General Assembly, Accessed 2023, https://legislature.vermont.gov/bill/status/2024/H.423. “H.371 2023-2024,” Vermont General Assembly, Accessed 2023, https://legislature.vermont.gov/bill/status/2024/H.371.
- 2022 Session: SB 262 Psilocybin or psilocyn; possession, civil penalty,” Virginia’s Legislative Information System, Accessed 2023, https://lis.virginia.gov/cgi-bin/legp604.exe?221+sum+SB262.
- “Certification of Enrollment, Second Substitute SEnate Bill 5263,” Washington Legislature, Accessed 2023, https://lawfilesext.leg.wa.gov/biennium/2023-24/Pdf/Bills/Senate%20Passed%20Legislature/5263-S2.PL.pdf#page=1. The original version of the bill would have legalized psilocybin. The watered-down version that passed created agencies to create a regulatory framework to have psilocybin at some point and ordered the University of Washington to offer psilocybin as allowed by FDA research.
- “S.B. No. 3160 S.D. 2,” The Senate Thirty-First Legislature, 2022, State of Hawaii, Accessed 2023, https://www.capitol.hawaii.gov/sessions/session2022/bills/SB3160_SD2_.HTM.
- “2023 Regular Session – HB 393,” New Mexico Legislature, Accessed 2023, https://www.nmlegis.gov/Legislation/Legislation?chamber=H&legtype=B&legno=393&year=23.
- “Bill History for HB2486,” Arizona State Legislature, Accessed 2023, https://apps.azleg.gov/BillStatus/BillOverview/78594.
- “HR 896: House Study Committee on Alternative Post-Traumatic Stress Disorder Treatment Resources for Veterans; create,” Georgia General Assembly, Accessed 2023, https://www.legis.ga.gov/legislation/62532.
- “HF 1884,” Minnesota Legislature, Accessed 2023, https://www.revisor.mn.gov/bills/text.php?number=HF1884&version=latest&session=92&session_number=0&session_year=2023.
- “Regular Session 2021-2022 House Bill 1959,” Pennsylvania General Assembly, Accessed 2023, https://www.legis.state.pa.us/cfdocs/billinfo/BillInfo.cfm?syear=2021&sind=0&body=H&type=B&bn=1959.
- “H.B. No. 1802,” Texas Legislature, Accessed 2023, https://capitol.texas.gov/tlodocs/87R/billtext/html/HB01802I.htm.
- “Drug Enforcement Administration,” DEA, Last modified September 27, 2018, https://www.dea.gov/press-releases/2018/09/27/fda-approved-drug-epidiolex-placed-schedule-v-controlled-substance-act.
- 21 USC §811.
- Barth Wilsey, “An Exploratory Human Laboratory Experiment Evaluating Vaporized Cannabis in the Treatment of Neuropathic Pain From Spinal Cord Injury and Disease,” The Journal of Pain, vol. 17,9 (2016): 982-1000, https://doi.org/10.1016/j.jpain.2016.05.010.
- “Denial of Petition To Initiate Proceedings To Reschedule Marijuana,” National Archives, Accessed 2023, https://www.federalregister.gov/documents/2016/08/12/2016-17960/denial-of-petition-to-initiate-proceedings-to-reschedule-marijuana.
- Yasemin Saplakoglu, “FDA Calls Psychedelic Psilocybin a ‘Breakthrough Therapy’ for Secere Depression,” LiveScience, Last modifed Noember 25, 2019, https://www.livescience.com/psilocybin-depression-breakthrough-therapy.html. “Compass Pathways receives FDA Breakthrough Therapy designation for psilocybin therapy for treatment-resistant depression,” Compass, Last modified October 23, 2018, https://compasspathways.com/compass-pathways-receives-fda-breakthrough-therapy-designation-for-psilocybin-therapy-for-treatment-resistant-depression/.
- 21 USC § 822
- “2022 Annual Report for the Center for Medical Cannabis,” Utah Department of Health & Human Services, Last modified 2022, https://medicalcannabis.utah.gov/wp-content/uploads/DHHS_Center-for-Medical-Cannabis-Annual-Report_2022.pdf.